← All Mutual Funds

BlackRock Health Sciences Trust

CIK: 0001314966 BME Equity
Report date: 2026-02-24
AUM $568M
Expense Ratio
Category Equity
State DE
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-02-24

About this Fund

The BlackRock Health Sciences Trust is a premier mutual fund company that specializes in providing a diverse range of investment solutions to help individuals and institutions achieve their long-term financial goals through effective asset management and wealth management strategies. With a strong focus on the health sciences sector, the company offers a variety of mutual funds that cater to different investor preferences and risk tolerance levels, including equity, debt, and hybrid funds. For investors seeking to capitalize on the growth potential of the healthcare industry, the BlackRock Health Sciences Trust provides a compelling opportunity to create a well-diversified portfolio that can help mitigate risk and maximize returns through a systematic investment plan, or SIP. The company's investment approach is centered on thorough research and analysis, leveraging the expertise of its experienced team of portfolio managers who work tirelessly to identify high-quality investment opportunities that align with the company's rigorous investment criteria. By prioritizing the needs of its investors, the BlackRock Health Sciences Trust has established itself as a trusted partner in the asset management industry, committed to delivering exceptional investment results and outstanding client service. With its extensive resources and global reach, the company is well-positioned to navigate the complexities of the investment landscape, providing its clients with access to a broad range of investment products and strategies that can help them achieve their unique financial objectives. Whether investors are seeking to build wealth over the long term or generate income through regular dividend payments, the BlackRock Health Sciences Trust offers a comprehensive suite of mutual funds that can help them succeed, backed by a proven track record of investment excellence and a deep commitment to responsible investing practices. As a leading player in the mutual fund industry, the BlackRock Health Sciences Trust has earned the trust of investors worldwide, who appreciate the company's unwavering dedication to helping them achieve their financial goals through a combination of investment expertise, innovative solutions, and exceptional client support. By choosing the BlackRock Health Sciences Trust, investors can tap into the company's extensive knowledge and experience in the health sciences sector, gaining a competitive edge in the pursuit of their investment objectives and enjoying the benefits of a well-managed portfolio that is tailored to their individual needs and circumstances. Through its mutual funds, the company provides investors with a convenient and cost-effective way to gain exposure to a broad range of asset classes and investment strategies, making it an ideal choice for those seeking to simplify their investment process and achieve their long-term financial aspirations. With its strong investment capabilities, robust risk management framework, and unyielding commitment to investor satisfaction, the BlackRock Health Sciences Trust has established itself as a trusted and reliable partner for investors seeking to navigate the complexities of the investment landscape and achieve their financial goals through a well-diversified portfolio of mutual funds.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

87 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
4.00%
$22.73 181,376
2 ABBV AbbVie Inc Since 2026-05-10 00287Y109 Equity (Common)
4.05%
$23.01 100,720
3 A Agilent Technologies Inc Since 2026-05-10 00846U101 Equity (Common)
0.83%
$4.72 34,724
4 AGIO Agios Pharmaceuticals Inc Since 2026-05-10 00847X104 Equity (Common)
0.14%
$0.82 30,245
5 ALLO Allogene Therapeutics Inc Since 2026-05-10 019770106 Equity (Common)
0.03%
$0.14 105,465
6 ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 02043Q107 Equity (Common)
1.66%
$9.44 23,741
7 COR Cencora Inc Since 2026-05-10 03073E105 Equity (Common)
1.23%
$6.99 20,687
8 AMGN Amgen Inc Since 2026-05-10 031162100 Equity (Common)
2.99%
$16.98 51,861
9 APGE Apogee Therapeutics Inc Since 2026-05-10 03770N101 Equity (Common)
0.24%
$1.34 17,780
10 ACLX Arcellx Inc Since 2026-05-10 03940C100 Equity (Common)
0.19%
$1.05 16,128
11 RCUS Arcus Biosciences Inc Since 2026-05-10 03969F109 Equity (Common)
0.17%
$0.94 39,654
12 BEAM Beam Therapeutics Inc Since 2026-05-10 07373V105 Equity (Common)
0.07%
$0.41 14,611
13 BIO-B Bio-Rad Laboratories Inc Since 2026-05-10 090572207 Equity (Common)
0.12%
$0.66 2,181
14 BMRN BioMarin Pharmaceutical Inc Since 2026-05-10 09061G101 Equity (Common)
0.31%
$1.76 29,577
15 BIIB Biogen Inc Since 2026-05-10 09062X103 Equity (Common)
0.60%
$3.44 19,524
16 AZN AstraZeneca PLC Since 2026-05-10 Equity (Common)
1.29%
$7.31 39,479
17 BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 107924102 Equity (Common)
0.13%
$0.75 60,030
18 BBIO Bridgebio Pharma Inc Since 2026-05-10 10806X102 Equity (Common)
0.24%
$1.38 18,055
19 CGON CG oncology Inc Since 2026-05-10 156944100 Equity (Common)
0.04%
$0.21 5,095
20 CRL Charles River Laboratories International Inc Since 2026-05-10 159864107 Equity (Common)
0.17%
$0.98 4,936
21 COGT Cogent Biosciences Inc Since 2026-05-10 19240Q201 Equity (Common)
0.23%
$1.33 37,385
22 DNLI Denali Therapeutics Inc Since 2026-05-10 24823R105 Equity (Common)
0.08%
$0.47 28,638
23 DXCM Dexcom Inc Since 2026-05-10 252131107 Equity (Common)
0.68%
$3.84 57,910
24 IRON Disc Medicine Inc Since 2026-05-10 254604101 Equity (Common)
0.11%
$0.60 7,529
25 DYN Dyne Therapeutics Inc Since 2026-05-10 26818M108 Equity (Common)
0.08%
$0.47 23,908
26 EWTX Edgewise Therapeutics Inc Since 2026-05-10 28036F105 Equity (Common)
0.10%
$0.55 22,279
27 ENTA Enanta Pharmaceuticals Inc Since 2026-05-10 29251M106 Equity (Common)
0.12%
$0.67 42,512
28 EXEL Exelixis Inc Since 2026-05-10 30161Q104 Equity (Common)
0.15%
$0.87 19,863
29 EYPT EyePoint Inc Since 2026-05-10 30233G209 Equity (Common)
0.05%
$0.30 16,320
30 FDMT 4D Molecular Therapeutics Inc Since 2026-05-10 35104E100 Equity (Common)
0.02%
$0.09 11,491
31 GEHC GE HealthCare Technologies Inc Since 2026-05-10 36266G107 Equity (Common)
0.30%
$1.72 20,917
32 GILD Gilead Sciences Inc Since 2026-05-10 375558103 Equity (Common)
3.25%
$18.47 150,487
33 GOSS Gossamer Bio Inc Since 2026-05-10 38341P102 Equity (Common)
0.02%
$0.10 31,955
34 GH Guardant Health Inc Since 2026-05-10 40131M109 Equity (Common)
0.55%
$3.14 30,762
35 HOLX Hologic Inc Since 2026-05-10 436440101 Equity (Common)
0.16%
$0.91 12,193
36 HUM Humana Inc Since 2026-05-10 444859102 Equity (Common)
0.30%
$1.73 6,765
37 IDXX IDEXX Laboratories Inc Since 2026-05-10 45168D104 Equity (Common)
0.80%
$4.54 6,712
38 ILMN Illumina Inc Since 2026-05-10 452327109 Equity (Common)
0.31%
$1.74 13,293
39 IMNM Immunome Inc Since 2026-05-10 45257U108 Equity (Common)
0.10%
$0.54 25,340
40 ISRG Intuitive Surgical Inc Since 2026-05-10 46120E602 Equity (Common)
2.74%
$15.58 27,505
41 IONS Ionis Pharmaceuticals Inc Since 2026-05-10 462222100 Equity (Common)
0.21%
$1.19 14,983
42 IQV IQVIA Holdings Inc Since 2026-05-10 46266C105 Equity (Common)
0.35%
$1.99 8,817
43 KALV KalVista Pharmaceuticals Inc Since 2026-05-10 483497103 Equity (Common)
0.05%
$0.30 18,705
44 KOD Kodiak Sciences Inc Since 2026-05-10 50015M109 Equity (Common)
0.08%
$0.46 16,563
45 KYMR Kymera Therapeutics Inc Since 2026-05-10 501575104 Equity (Common)
0.06%
$0.37 4,712
46 LBRX LB Pharmaceuticals Inc Since 2026-05-10 50180M108 Equity (Common)
0.19%
$1.07 48,308
47 MBX MBX Biosciences Inc Since 2026-05-10 55287L101 Equity (Common)
0.16%
$0.90 28,457
48 MAZE Maze Therapeutics Inc Since 2026-05-10 578784100 Equity (Common)
0.12%
$0.66 15,965
49 MRK Merck & Co Inc Since 2026-05-10 58933Y105 Equity (Common)
3.65%
$20.73 196,949
50 MTD Mettler-Toledo International Inc Since 2026-05-10 592688105 Equity (Common)
0.10%
$0.55 395
51 MRNA Moderna Inc Since 2026-05-10 60770K107 Equity (Common)
0.25%
$1.44 48,852
52 NTRA Natera Inc Since 2026-05-10 632307104 Equity (Common)
0.48%
$2.71 11,821
53 NBIX Neurocrine Biosciences Inc Since 2026-05-10 64125C109 Equity (Common)
0.17%
$0.96 6,793
54 NVS Novartis AG Since 2026-05-10 66987V109 Equity (Common)
0.53%
$3.01 21,810
55 NUVL Nuvalent Inc Since 2026-05-10 670703107 Equity (Common)
0.51%
$2.88 28,618
56 NUVB Nuvation Bio Inc Since 2026-05-10 67080N119 Derivative
0.00%
$0.00 4,050
57 OCUL Ocular Therapeutix Inc Since 2026-05-10 67576A100 Equity (Common)
0.05%
$0.28 22,645
58 OLMA Olema Pharmaceuticals Inc Since 2026-05-10 68062P106 Equity (Common)
0.10%
$0.56 22,205
59 OBIO Orchestra BioMed Holdings Inc Since 2026-05-10 68572M106 Equity (Common)
0.01%
$0.07 17,635
60 ORKA Oruka Therapeutics Inc Since 2026-05-10 687604108 Equity (Common)
0.09%
$0.48 15,986
61 PTCT PTC Therapeutics Inc Since 2026-05-10 69366J200 Equity (Common)
0.10%
$0.55 7,270
62 PEN Penumbra Inc Since 2026-05-10 70975L107 Equity (Common)
0.63%
$3.61 11,606
63 PFE Pfizer Inc Since 2026-05-10 717081103 Equity (Common)
0.45%
$2.58 103,734
64 PTGX Protagonist Therapeutics Inc Since 2026-05-10 74366E102 Equity (Common)
0.49%
$2.80 32,058
65 RDNT RadNet Inc Since 2026-05-10 750491102 Equity (Common)
0.12%
$0.68 9,485
66 REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 75886F107 Equity (Common)
1.05%
$5.95 7,712
67 RGNX REGENXBIO Inc Since 2026-05-10 75901B107 Equity (Common)
0.05%
$0.27 18,415
68 RYTM Rhythm Pharmaceuticals Inc Since 2026-05-10 76243J105 Equity (Common)
0.88%
$5.01 46,799
69 STOK Stoke Therapeutics Inc Since 2026-05-10 86150R107 Equity (Common)
0.23%
$1.30 41,095
70 SMMT Summit Therapeutics Inc Since 2026-05-10 86627T108 Equity (Common)
0.25%
$1.40 80,150
71 TERN Terns Pharmaceuticals Inc Since 2026-05-10 880881107 Equity (Common)
0.20%
$1.14 28,220
72 TMO Thermo Fisher Scientific Inc Since 2026-05-10 883556102 Equity (Common)
2.76%
$15.68 27,058
73 TCRX TScan Therapeutics Inc Since 2026-05-10 89854M101 Equity (Common)
0.01%
$0.05 48,273
74 UPB Upstream Bio Inc Since 2026-05-10 91678A107 Equity (Common)
0.14%
$0.82 30,052
75 PCVX Vaxcyte Inc Since 2026-05-10 92243G108 Equity (Common)
0.06%
$0.35 7,541
76 VEEV Veeva Systems Inc Since 2026-05-10 922475108 Equity (Common)
0.34%
$1.94 8,702
77 VIR Vir Biotechnology Inc Since 2026-05-10 92764N102 Equity (Common)
0.02%
$0.12 20,069
78 VOR Vor BioPharma Inc Since 2026-05-10 929033207 Equity (Common)
0.02%
$0.13 10,020
79 VYGR Voyager Therapeutics Inc Since 2026-05-10 92915B106 Equity (Common)
0.02%
$0.12 31,420
80 WST West Pharmaceutical Services Inc Since 2026-05-10 955306105 Equity (Common)
0.48%
$2.73 9,928
81 BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC Since 2026-05-10 Equity (Common)
0.03%
$0.20 15,582
82 NYXH Nyxoah SA Since 2026-05-10 Equity (Common)
0.02%
$0.14 29,659
83 BHVN Biohaven Ltd Since 2026-05-10 Equity (Common)
0.06%
$0.34 30,469
84 MDT Medtronic PLC Since 2026-05-10 Equity (Common)
3.12%
$17.74 184,666
85 ROIV Roivant Sciences Ltd Since 2026-05-10 Equity (Common)
0.16%
$0.89 41,221
86 STE STERIS PLC Since 2026-05-10 Equity (Common)
0.26%
$1.49 5,880
87 WVE WaVe Life Sciences Ltd Since 2026-05-10 Equity (Common)
0.09%
$0.51 30,090
Frequently Asked Questions — BlackRock Health Sciences Trust
What type of mutual fund is BlackRock Health Sciences Trust?
BlackRock Health Sciences Trust is a SEC-registered Equity fund, with $568M in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, BlackRock Health Sciences Trust holds 87 portfolio positions, all detailed in the holdings table on this page.
What are BlackRock Health Sciences Trust's assets under management (AUM)?
BlackRock Health Sciences Trust has $568M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are BlackRock Health Sciences Trust's top holdings?
According to BlackRock Health Sciences Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie Inc, Agilent Technologies Inc , among others. The complete list of all 87 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is BlackRock Health Sciences Trust's expense ratio?
Expense ratio data for BlackRock Health Sciences Trust is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find BlackRock Health Sciences Trust's SEC filings?
BlackRock Health Sciences Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001314966. You can access all of BlackRock Health Sciences Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001314966). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is BlackRock Health Sciences Trust's holdings data on StockSifting?
Holdings data for BlackRock Health Sciences Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.